Amicus Therapeutics US, LLC et al v. Teva Pharmaceuticals USA, Inc. et al
| Amicus Therapeutics US, LLC and Amicus Therapeutics, Inc. |
| Teva Pharmaceuticals USA, Inc., Teva Pharmaceuticals, Inc. and Teva Pharmaceutical Industries Ltd. |
| 1:2022cv01461 |
| November 7, 2022 |
| U.S. District Court for the District of Delaware |
| Colm F Connolly |
| Patent - Abbreviated New Drug Application(ANDA) |
| 35 U.S.C. § 271 Patent Infringement |
| None |
Docket Report
RSS Track this Docket
This docket was last retrieved on August 17, 2023. A more recent docket listing may be available from PACER.
| Document Text |
|---|
| Filing 13 Disclosure Statement pursuant to Rule 7.1: identifying Other Affiliate Teva Pharmaceutical Industries Ltd. for Teva Pharmaceuticals USA, Inc., Teva Pharmaceuticals, Inc. filed by Teva Pharmaceutical Industries Ltd., Teva Pharmaceuticals USA, Inc., Teva Pharmaceuticals, Inc.. (Hoeschen, Nathan) |
| Filing 12 ANSWER to #1 Complaint, , COUNTERCLAIM against Amicus Therapeutics US, LLC, Amicus Therapeutics, Inc. by Teva Pharmaceuticals, Inc., Teva Pharmaceutical Industries Ltd., Teva Pharmaceuticals USA, Inc..(Hoeschen, Nathan) |
| Filing 11 MOTION for Pro Hac Vice Appearance of Attorney John W. Cox, Ph.D., Mark C. Nelson, Christina M. Baugh, Josh E. Ney, Ph.D., Heather B. Repicky, Joshua M. Kalb, Lauren Baker and Anna Whitacre - filed by Amicus Therapeutics US, LLC, Amicus Therapeutics, Inc.. (Stover, Chad) |
SO ORDERED, re (11 in 1:22-cv-01462-CFC) (16 in 1:22-cv-01465-CFC) (11 in 1:22-cv-01461-CFC) (12 in 1:22-cv-01467-CFC) MOTION for Pro Hac Vice Appearance of Attorney John W. Cox, Ph.D., Mark C. Nelson, Christina M. Baugh, Josh E. Ney, Ph.D., Heather B. Repicky, Joshua M. Kalb, Lauren Baker and Anna Whitacre, filed by Amicus Therapeutics, Inc., Amicus Therapeutics US, LLC. Ordered by Judge Colm F. Connolly on 12/7/2022. Associated Cases: 1:22-cv-01461-CFC, 1:22-cv-01462-CFC, 1:22-cv-01465-CFC, 1:22-cv-01467-CFC(kmd)
|
| Filing 10 AFFIDAVIT of Service for Complaint served on counsel for Teva Pharmaceuticals USA, Inc. on 11/30/2022, filed by Amicus Therapeutics US, LLC, Amicus Therapeutics, Inc.. (Stover, Chad) |
|
SO ORDERED, re #9 STIPULATION TO EXTEND TIME for Defendants Teva Pharmaceuticals USA, Inc. and Teva Pharmaceuticals, Inc. to move, plead, or otherwise respond to the complaints to January 6, 2023, filed by Teva Pharmaceuticals USA, Inc., Teva Pharmaceuticals, Inc., Teva Pharmaceuticals USA, Inc. Reset Answer Deadlines: Teva Pharmaceuticals USA, Inc. answer due 1/6/2023; Teva Pharmaceuticals, Inc. answer due 1/6/2023. Ordered by Judge Colm F. Connolly on 11/30/2022. (kmd)
|
| Filing 9 STIPULATION TO EXTEND TIME for Defendants Teva Pharmaceuticals USA, Inc. and Teva Pharmaceuticals, Inc. to move, plead, or otherwise respond to the complaints to January 6, 2023 - filed by Teva Pharmaceuticals USA, Inc., Teva Pharmaceuticals, Inc., Teva Pharmaceuticals USA, Inc.. (Keller, Karen) |
| Case Assigned to Judge Colm F. Connolly. Please include the initials of the Judge (CFC) after the case number on all documents filed. Associated Cases: 1:22-cv-01461-CFC, 1:22-cv-01462-CFC, 1:22-cv-01465-CFC, 1:22-cv-01467-CFC (rjb) |
| Filing 8 SUMMONS Returned Executed by Amicus Therapeutics US, LLC, Amicus Therapeutics, Inc..Teva Pharmaceuticals USA, Inc. served on 11/8/2022, answer due 11/29/2022. (Stover, Chad) |
| Filing 7 Summons Issued as to All Defendants. (Attachments: #1 Summons Issued, #2 Summons Issued) (vfm) |
| Filing 6 Disclosure Statement pursuant to Rule 7.1: No Parents or Affiliates Listed filed by Amicus Therapeutics, Inc.. (vfm) |
| Filing 5 Disclosure Statement pursuant to Rule 7.1: No Parents or Affiliates Listed filed by Amicus Therapeutics US, LLC. (vfm) |
| Filing 4 Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 9,000,011 ;9,987,263 ;10,383,864 ;10,406,143 ;9,999,618 ;10,925,866 ;10,813,921 ;RE 48,608. (vfm) |
| Filing 3 Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 10/06/2022. Date of Expiration of Patent: See Attached.Thirty Month Stay Deadline: 2/10/2026. (vfm) |
| Filing 2 Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (vfm) |
| Filing 1 COMPLAINT for ANDA/PATENT INFRINGEMENT against All Defendants (Filing fee $ 402, receipt number ADEDC-4000296.) - filed by Amicus Therapeutics US, LLC, Amicus Therapeutics, Inc. (Attachments: #1 Exhibit A, #2 Exhibit B, #3 Exhibit C, #4 Exhibit D, #5 Exhibit E, #6 Exhibit F, #7 Exhibit G, #8 Exhibit H, #9 Civil Cover Sheet) (vfm) |
Access additional case information on PACER
Use the links below to access additional information about this case on the U.S. Court's PACER system. A subscription to PACER is required.
Access this case on the Delaware District Court's Electronic Court Filings (ECF) System
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
